BEIJING, Sept. 6 (Xinhua) -- Shanghai Institute of
Biological Products has been advised by the National Institute for the Control
of Pharmaceutical and Biological Products in Beijing to have its H1N1 vaccine
tested, the English Shanghai Daily reported Sunday.
"We will send our vaccine for evaluation by a panel
of experts for a production license," Shao Jun from the Shanghai institute was
quoted as saying by the newspaper.
"The conference could be held next week," Shao said.
If approved, the Shanghai manufacturer would be the country's third licensed
mass producer of A/H1N1 flu vaccine.
World Tackles A/H1N1